ÂÜÀòÂÒÂ×

Alastair Garfield is an accomplished scientific leader with extensive experience in the pharmaceutical industry and academia. Currently serving as Chief Scientific Officer at Rhythm Pharmaceuticals Inc. since July 2024, Garfield has previously held significant roles including Head of Translational Sciences and Strategy at Rectify Pharma and Senior Vice President, Head of Research at Rhythm Pharmaceuticals. Key contributions include leading late-stage clinical assets through development and regulatory processes, establishing a precision medicine infrastructure for rare genetic diseases, and guiding translational research for preclinical and clinical pipelines. Garfield's academic background features positions as an Honorary Fellow at The University of Edinburgh and research roles at Pfizer and Beth Israel Deaconess Medical Center, where impactful studies on appetite regulation and metabolic processes were conducted. Garfield's educational credentials include a PhD in Developmental Genetics and Neuroscience from the University of Bath.